Collaboratory Treatment Pathway for Chronic Pain Patients.

Brief summary (registry, in English)

In this multicenter randomized controlled trial, the aim is to evaluate the effectiveness of a standardized treatment pathway (STP) for patients referred to four participating pain clinics, by comparing it to treatment as usual (TAU) which is standard care at the clinics. The STP differs from TAU in two key aspects: * Structured cross-sector collaboration: Involvement of primary healthcare providers, particularly the patient's GP, in two digital collaborative meetings with the pain clinic. * Time-bound treatment pathway: A clearly defined treatment trajectory with follow-up over a six-month period. The study aims to answer whether the STP give larger improvements than TAU in the following outcomes: * patients´ reported overall impression of change in health (primary outcome) * pain interference (primary outcome) * physical function and mental health * satisfaction with and experience of continuity and integration of the health care services All study participants will follow an initial care pathway at the pain clinic, which includes: * a screening consultation with a study coordinator * a multidisciplinary clinical assessment based on a biopsychosocial approach by at least to health care professions. The specific professional groups included in each assessment are determined individually based on patient needs. The control group: This group will receive standard care at the pain clinic. This will vary somewhat between the four pain clinics , but almost all patients will be offered a summary consultation with the pain clinic team where further plans for follow-up will be discussed. Some patients will be offered further treatment at the pain clinic. All clinics will send a clinical summary to the referring physician with suggestions for further follow-up. If further collaboration with primary care is needed, it may preferably be written or arranged via telephone. Digital collaborative meeting will not be offered to this group. The intervention group: All patients in this group will be offered the STP with two digital collaborative meetings as described above.

What you commit to

• Study type: Interventional
• Planned participants: 386
• From 19 Dec 2025 to the primary completion date, 31 Dec 2028
• 4 sites in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.